US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease-March 2024-www.financetom.com

US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease

Oct 22, 2024 2:32 PM

Oct 22 (Reuters) - The U.S. Food and Drug Administration

on Tuesday approved Pfizer's ( PFE ) RSV vaccine for the

prevention of lower respiratory tract disease caused by RSV in

adults aged 18 to 59 at increased risk of the disease.

Previous page： Sector Update: Consumer Stocks Rise Pre-Bell Tuesday Next page： Knight Therapeutics Applies to Expand Minjuvi Indications in Argentina, Mexico

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sector Update: Consumer Stocks Rise Pre-Bell Tuesday

Mar 17, 2026

09:13 AM EDT, 03/17/2026 (MT Newswires) -- Consumer stocks were rising pre-bell Tuesday, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) advancing by 0.2% and the State Street Consumer Discretionary Select Sector ETF (XLY) up 0.4%. Atour Lifestyle ( ATAT ) stock was up 2.5% after the company posted higher Q4 adjusted net income and revenue. Academy...

Knight Therapeutics Applies to Expand Minjuvi Indications in Argentina, Mexico

Mar 17, 2026

08:31 AM EDT, 03/17/2026 (MT Newswires) -- Knight Therapeutics ( KHTRF ) Tuesday said it submitted a supplemental application to the Argentine and Mexican health regulatory agencies, to expand the treatment indications for Minjuvi (tafasitamab). The additional indication for Minjuvi is in combination with lenalidomide and rituximab, to treat adult patients with relapsed or refractory follicular lymphoma (FL) (Grade 1-3a)...

Ondas Acquires INDO Earth Moving Ltd. Following its $140 Million Strategic Procurement Tender Award for Military Heavy Engineering Platforms from a Major Military Customer

Mar 17, 2026

Acquisition Positions Ondas to Deliver Multi-Year Military Engineering Vehicle Program as a Prime Contractor and Advance Future Robotic Heavy Engineering Platform Capabilities Transaction Expands Ondas Autonomous Systems into Robotic Heavy Engineering Platforms Through Synergies with 4M Defense, Roboteam, and Apeiro Motion Ground Systems $140 Million Military Engineering Vehicle Tender Expected to Begin Revenue Generation in Q2 2026 While Driving Operating...

Cencora CFO James Cleary to Step Down

Mar 17, 2026

09:13 AM EDT, 03/17/2026 (MT Newswires) -- Cencora ( COR ) said Tuesday that James Cleary will step down as executive vice president and chief financial officer, effective June 30. The company has started the process to identify and evaluate potential successors from both internal and external candidates, Cencora ( COR ) said. Cleary will assist in the search process...